Crossmark

Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma

Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P353

Published Online: 2015-11-04

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Atkins, Michael B

Gupta, Shilpa

Choueiri, Toni K

McDermott, David F

Puzanov, Igor

Tarazi, Jamal

Keefe, Stephen

Rosbrook, Brad

Chakrabarti, Debasis

Plimack, Elizabeth R
More Information

Article History

First Online: 4 November 2015